JPMorgan Chase & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2M | Sell |
|
|||||
|
2025
Q1 | $32.5M | Sell |
|
|||||
|
2024
Q4 | $65.9M | Buy |
|
|||||
|
2024
Q3 | $36.4M | Sell |
|
|||||
|
2024
Q2 | $81.8M | Buy |
|
|||||
|
2024
Q1 | $42.4M | Buy |
|
|||||
|
2023
Q4 | $22.1M | Buy |
|
|||||
|
2023
Q3 | $9.79M | Sell |
|
|||||
|
2023
Q2 | $8.38M | Sell |
|
|||||
|
2023
Q1 | $11.3M | Buy |
|
|||||
|
2022
Q4 | $5.58M | Buy |
|
|||||
|
2022
Q3 | $4.88M | Buy |
|
|||||
|
2022
Q2 | $4.05M | Sell |
|
|||||
|
2022
Q1 | $5.12M | Sell |
|
|||||
|
2021
Q4 | $4.92M | Buy |
|
|||||
|
2021
Q3 | $5.75M | Sell |
|
|||||
|
2021
Q2 | $18.6M | Sell |
|
|||||
|
2021
Q1 | $39.8M | Buy |
|
|||||
|
2020
Q4 | $27.8M | Sell |
|
|||||
|
2020
Q3 | $37.9M | Buy |
|
|||||
|
2020
Q2 | $34.3M | Sell |
|
|||||
|
2020
Q1 | $32.2M | Sell |
|
|||||
|
2019
Q4 | $44M | Buy |
|
|||||
|
2019
Q3 | $16.4M | Sell |
|
|||||
|
2019
Q2 | $38.7M | Buy |
|
|||||
|
2019
Q1 | $37.4M | Buy |
|
|||||
|
2018
Q4 | $29.2M | Sell |
|
|||||
|
2018
Q3 | $44.8M | Sell |
|
|||||
|
2018
Q2 | $103M | Sell |
|
|||||
|
2018
Q1 | $348M | Buy |
|
|||||
|
2017
Q4 | $44.3M | Buy |
|
|||||
|
2017
Q3 | $34.7M | Sell |
|
|||||
|
2017
Q2 | $239M | Sell |
|
|||||
|
2017
Q1 | $250M | Sell |
|
|||||
|
2016
Q4 | $324M | Sell |
|
|||||
|
2016
Q3 | $492M | Buy |
|
|||||
|
2016
Q2 | $365M | Buy |
|
|||||
|
2016
Q1 | $300M | Buy |
|
|||||
|
2015
Q4 | $320M | Buy |
|
|||||
|
2015
Q3 | $223M | Sell |
|
|||||
|
2015
Q2 | $268M | Buy |
|
|||||
|
2015
Q1 | $216M | Sell |
|
|||||
|
2014
Q4 | $202M | Sell |
|
|||||
|
2014
Q3 | $212M | Buy |
|
|||||
|
2014
Q2 | $200M | Buy |
|
|||||
|
2014
Q1 | $184M | Buy |
|
|||||
|
2013
Q4 | $131M | Sell |
|
|||||
|
2013
Q3 | $131M | Sell |
|
|||||
|
2013
Q2 | $149M | Buy |
|